Overexpression of MDM2 results in decreased level and activity of p53 (Kubbutat et al, 1997) and provides an alternative to a p53 mutation in the sense that it inactivates p53
Collectively, this study revealed that a signaling cascade comprising Src, PDK1, Akt, and ubiquitin-specific protease 33 (USP33) mediate arrestin deubiquitination and acute receptor desensitization by sequestering G in the nucleus
PMID: 34752566
Sbraccia, P., Aberle, J., Olsen, A
As research continues, we can expect even more innovative options to become available, offering hope for those who suffer from chronic migraines
The Pediatric Neurology Advisory Committee in 1996 and some textbooks and manuals strongly recommended carnitine supplementation (50100 mg/kg per day) during VPA therapy for children at risk for developing a carnitine deficiency, in VPA overdose and in VHT [33, 92, 93]